Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial-Reference-Cited by-同舟云学术

Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial

Published:2019-03-29 Issue:2 Volume:44 Page:353-361
ISSN:0307-0565
Container-title:International Journal of Obesity
language:en
Short-container-title:Int J Obes

Author:

Tronieri Jena Shaw^ORCID,Wadden Thomas A.,Walsh Olivia,Berkowitz Robert I.,Alamuddin Naji,Gruber Kathryn,Leonard Sharon,Bakizada Zayna M.,Chao Ariana M.

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

http://www.nature.com/articles/s41366-019-0348-6.pdf

Reference30 articles.

1. Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Phelan S, Cato RK, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 2005;353:2111–20.

2. Craighead LW, Stunkard AJ, O’Brien RM. Behavior therapy and pharmacotherapy for obesity. Arch Gen Psychiatry. 1981;38:763–68.

3. Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C. Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. Arch Intern Med. 2001;161:218–27.

4. Phelan S, Wadden TA. Combining behavioral and pharmacological treatments for obesity. Obes Res. 2002;10:560–74.

5. Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315:2424–34.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs;Obesity Pillars;2024-09

2. Medical Nutrition Therapy: Still Relevant in the Era of Pharmacotherapy for Obesity Care;Journal of the Academy of Nutrition and Dietetics;2024-06

3. Single‐Administration Self‐Boosting Microneedle Patch for the Treatment of Obesity;Advanced Therapeutics;2024-05-21

4. Food Cravings and Obesity in Women with Polycystic Ovary Syndrome: Pathophysiological and Therapeutic Considerations;Nutrients;2024-04-03

5. Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities;International Journal of Obesity;2024-03-07